The goal of this clinical trial is to learn if tranilast works to prevent esophageal stricture after circumferential endoscopic submucosal dissection (cESD) in adults. It will also help us learn more about the safety of tranilast. The main questions it aims to answer are: 1. Does tranilast reduce the occurence of esophageal stricture in participants after cESD? 2. What medical problems do participants have when taking tranilast.
Researchers will compare tranilast to prednisone (a steroid used in clinical practice with potential defects) to see if tranilast works well to prevent esophageal stricture.
Participants will: 1. Take tranilast or prednisone every day for 8 weeks. 2. Attend visit (at clinic or phone) once every 2 weeks for checkups and tests until 16 weeks. 3. Keep a diary of their symptoms and let researchers know during the 16 weeks follow up.
age>18 and proficient in Mandarin.
underwent cESD treatment for superficial esophageal neoplasms.
agree to sign an informed consent form.
allergic to tranilast.
with severe comorbid conditions.
pregnant or breastfeeding.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor
The Third People's Hospital of Hangzhou
Collaborator
Xiangya Hospital of Central South University
Collaborator